Jianying Yan

Dr. Jianying Yan


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2025 in Cellular Signalling
Verified
Journal Article
Closed access
LQLiyin Qiu
Liyin Qiu
HLHui Liu
Hui Liu
SCShali Chen
Shali Chen
YWYiting Wu
Yiting Wu
JYJianying Yan
Jianying Yan

26 March 2024 in American Journal of Reproductive Immunology
Verified
Journal Article
Closed access
LQLiyin Qiu
Liyin Qiu
HLHui Liu
Hui Liu
SCShali Chen
Shali Chen
YWYiting Wu
Yiting Wu
JYJianying Yan
Jianying Yan

18 June 2024 in Heliyon
Verified
Journal Article
Open access
LQLiyin Qiu
Liyin Qiu
ZLZhaozhen Liu
Zhaozhen Liu
SCShouzhen Chen
Shouzhen Chen
YWYiting Wu
Yiting Wu
JYJianying Yan
Jianying Yan
Premature birth (PTB) is a major cause of neonatal mortality and has enduring consequences. LIM Homeobox 1 (LHX1) is vital in embryonic organogenesis, while Inositol-Requiring Enzyme 1 (IRE-1) regulates endoplasmic reticulum stress (ERS). This study explores whether IRE-1 impacts PTB via LHX1 modulation. We analyzed LHX1 expression in placental samples from PTB patients and examined its impact on the viability, migration, invasion, and apoptosis of the human placental trophoblast cell line HTR8/Svneo, particularly when treated with the ERS inducer tunicamycin (TM). We also assessed the levels of ERS-related genes and autophagy activation in response to LHX1 deficiency. To gain mechanistic insights, we evaluated the ERS-mediated activation of the IRE-1/XBP1/CHOP signaling pathway in LHX1-silenced HTR8/Svneo cells. Additionally, we examined the transcriptional activation of IRE-1 and the binding of LHX1 to the IRE-1 promoter in HTR8/Svneo cells. We overexpressed IRE-1 in LHX1-silenced HTR8/Svneo cells to assess its effects on cell viability, migration, invasion, apoptosis, and autophagy. Finally, we induced LHX1 knockdown in mice through intraperitoneal injections of tunicamycin (TM) and Sh-LHX1 over a 24-h period to evaluate PTB symptoms. We observed LHX1 overexpression in placental tissue from PTB cases and TM-induced HTR8/Svneo cells. LHX1 depletion enhanced cell viability, migration, and invasion while reducing autophagy and apoptosis. This reduction in LHX1 led to decreased levels of IRE-1, XBP1, CHOP, and other ERS-related genes, indicating LHX1's role in ERS induction and the activation of the IRE-1/XBP1/CHOP pathway. Mechanistically, LHX1 was found to bind to the IRE-1 promoter, inducing its transcriptional activation. Notably, overexpressing IRE-1 counteracted the impact of LHX1 depletion on trophoblast cell behavior, suggesting that LHX1 modulates IRE-1. In line with our in vitro studies, LHX1 knockdown ameliorated PTB symptoms in TM-treated mice. LHX1 contributes to the progression of PTB by regulating the IRE-1-XBP1-CHOP pathway.

10 December 2023 in Cellular and Molecular Biology
Verified
Journal Article
Open access
PDF file
LQLiyin Qiu
Liyin Qiu
XLXiaoqian Lin
Xiaoqian Lin
RCRuiyun Chen
Ruiyun Chen
YWYiting Wu
Yiting Wu
JYJianying Yan
Jianying Yan
Long non-coding RNAs (lncRNAs) have a vital potential in premature delivery. This research was intended to explore PSMA3-AS1’s role in premature delivery as well as its possible molecular mechanism. We enrolled 100 premature delivery patients and 100 term patients. Fetal membranes were collected. RT-qPCR was adopted for evaluating PSMA3-AS1, miRNA-224-3p, along with Nrf2 expression. Cell function experiments were implemented to clarify PSMA3-AS1 functions in human trophoblast HTR-8/SVneo cells. Rescue together with mechanistic experiments were implemented for assessing the regulatory function and interaction between miR-224-3p and PSMA3-AS1 or Nrf2 axis in human trophoblast cells. The results uncovered that PSMA3-AS1 level presented downregulation in the fetal membrane tissues and human trophoblast cells. Overexpressed PSMA3-AS1 enhanced cell proliferation but suppressed ferroptosis in human trophoblast cells. Besides, PSMA3-AS1 elevation also attenuated the LPS-induced inflammatory response and restored the LPS-induced upregulation of 20α-HSD and downregulation of progesterone (P4). Mechanistically, miR-224-3p could bind to PSMA3-AS1 and present upregulation in fetal membranes and human trophoblast cells. Notably, overexpressed miR-224-3p offset the influences of PSMA3-AS1 on human trophoblast cell proliferation and ferroptosis. Furthermore, Nrf2 was targeted by miR-224-3p. Downregulated Nrf2 offset the influences of the miR-224-3p inhibitor and induced HTR-8/SVneo dysfunction. Additionally, Nrf2 transcriptionally activated PSMA3-AS1 and GPX4. In conclusion, PSMA3-AS1 expression is low during premature delivery and overexpressing PSMA3-AS1 promotes proliferation and suppresses ferroptosis of human trophoblast cells by interacting with miR-224-3p to downregulate Nrf2. Therefore, enhancing PSMA3-AS1 expression may be a promising therapeutic strategy to prevent premature delivery.

5 March 2025 in Clinical and Experimental Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
YZYizheng Zu
Yizheng Zu
XXXia Xu
Xia Xu
XXXiaoyan Xiu
Xiaoyan Xiu
YXYi Xie
Yi Xie
HYHuangchang Yi
Huangchang Yi
JYJianying Yan
Jianying Yan
Background: This study aimed in this study was to investigate the association between poor sleep patterns (PSPs) and type 2 diabetes mellitus (T2DM) in women with a history of gestational diabetes mellitus (GDM). Methods: Our analysis was based on a population-based sample from National Health and Nutrition Examination Survey (NHANES) data collected between 2007 and 2018. The association between PSPs and T2DM in women with a history of GDM was assessed using logistic regression models. We performed subgroup analyses stratified by age, body mass index (BMI), race, educational level, moderate recreational activities, smoking behavior, and parity. Results: A total of 917 women with a history of GDM were included in our study. Compared to the non-PSPs group, participants with PSPs had a higher possibility for T2DM in women with a history of GDM (odds ratio (OR) = 2.37, 95% confidence interval (CI): 1.45–3.86). Furthermore, this association was more prominent in those aged between 35 and 49 (OR = 2.20, 95% CI: 1.03–4.71), a BMI ≥30 kg/m2 (OR = 2.56, 95% CI: 1.43–4.60), non-Hispanic white (OR = 5.34, 95% CI: 2.09–13.66) or non-Hispanic black (OR = 5.02, 95% CI: 1.48–17.06), educated beyond high school (OR = 2.65, 95% CI: 1.35–5.23), not engaged in moderate recreational activities (OR = 3.25, 95% CI: 1.72–6.14) groups and parity ≥4 (OR = 2.62, 95% CI: 1.03–6.63). Conclusions: Our findings suggest that PSPs are positively associated with the prevalence of T2DM in women with a history of GDM, which demonstrates that we need targeted interventions, especially for those at high risk. Future research should evaluate how sleep patterns affect metabolic health and develop new ways to lower the risk of T2DM in women with a history of GDM.